Ai Feedback
Exact(7)
Particularly, the average peak areas of cyclohexanone and 2-ethyl-1-hexanol in malignant effusions were significantly higher than those in benign ones.
Malignant effusions were confirmed by pathological diagnosis.
Malignant effusions were diagnosed by cytological or histological examination.
Taken as a group, 11% of non-MM malignant effusions were mesothelin positive.
Cells obtained from the malignant effusions were adjusted to 100 000 cells ml−1 in CAM.
Malignant effusions were obtained from forty-six patients who have been histological or cytological diagnosis as stage IV malignant disease.
Similar(53)
Malignant effusions are typically due to direct pleural involvement by the neoplasm.
To date, studies regarding the presence of calprotectin in malignant effusions are scarce.
Viable tumor cells obtained from malignant effusions are tested for their sensitivity to cisplatin and docetaxel using ATP-TCA assay.
Our study showed that patients with higher BRCA1 level in malignant effusions are more sensitive to docetaxel than those with lower level.
The general approach to managing malignant effusions is determined by symptoms, performance status of the patient, expected survival and response of the known primary tumor to systemic treatment.
Related(20)
malignant abnormalities were
malignant pathologies were
malignant lesions were
malignant conditions were
malignant tumors were
malignant variants were
malignant indications were
malignant transformations were
malignant mesotheliomas were
malignant outcomes were
malignant cells were
malignant paragangliomas were
malignant cysts were
malignant hepatocytes were
malignant findings were
malignant tumours were
malignant polyps were
malignant neoplasms were
malignant components were
malignant effusions originated
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com